Have a feature idea you'd love to see implemented?
Let us know!
PROK ProKidney Corp
Price (delayed)
$1.74
Market cap
$507.49M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.55
Enterprise value
$405.84M
Highlights
ProKidney's equity has increased by 10% YoY
The EPS has increased by 7% since the previous quarter and by 5% year-on-year
ProKidney's debt has soared by 131% YoY but it has decreased by 3.5% from the previous quarter
The net income has declined by 26% year-on-year and by 18% since the previous quarter
PROK's quick ratio is down by 23% QoQ and by 14% YoY
Key stats
What are the main financial stats of PROK
Market
Valuations
Earnings
Shares outstanding
291.66M
Market cap
$507.49M
Enterprise value
$405.84M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$45.11M
EBITDA
-$40.1M
Free cash flow
-$133.14M
Per share
Balance sheet
Liquidity
EPS
-$0.55
Free cash flow per share
-$1.06
Book value per share
-$3.38
Revenue per share
$0
TBVPS
$3.76
Total assets
$474.79M
Total liabilities
$31.33M
Debt
$6.44M
Equity
-$979.71M
Working capital
$405.04M
Debt to equity
-0.01
Current ratio
17.09
Quick ratio
16.16
Net debt/EBITDA
2.53
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-10.2%
Return on equity
N/A
Return on invested capital
-14.5%
Return on capital employed
-10%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PROK stock price
How has the ProKidney stock price performed over time
Intraday
5.45%
1 week
-19.07%
1 month
-6.95%
1 year
-6.45%
YTD
-2.25%
QTD
-9.38%
Financial performance
How have ProKidney's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$156.32M
Net income
-$45.61M
Gross margin
N/A
Net margin
N/A
The net income has declined by 26% year-on-year and by 18% since the previous quarter
Growth
What is ProKidney's growth rate over time
Valuation
What is ProKidney stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 7% since the previous quarter and by 5% year-on-year
ProKidney's equity has increased by 10% YoY
Efficiency
How efficient is ProKidney business performance
The return on assets has declined by 38% year-on-year and by 16% since the previous quarter
The return on invested capital rose by 26% year-on-year but it has declined by 19% since the previous quarter
Dividends
What is PROK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PROK.
Financial health
How did ProKidney financials performed over time
ProKidney's total liabilities has increased by 33% YoY and by 17% QoQ
PROK's quick ratio is down by 23% QoQ and by 14% YoY
ProKidney's debt is 101% more than its equity
ProKidney's debt has soared by 131% YoY but it has decreased by 3.5% from the previous quarter
ProKidney's equity has increased by 10% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.